Verona Pharma PLC Holding(s) in Company (2454G)
August 04 2016 - 3:45AM
UK Regulatory
TIDMVRP
RNS Number : 2454G
Verona Pharma PLC
04 August 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Verona Pharma Plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------------- ---------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
---------------------------------------------------------------- ------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
---------------------------------------------------------------- ------------------
An acquisition or disposal of instruments with X
similar economic effect to qualifying financial
instruments
---------------------------------------------------------------- ------------------
An event changing the breakdown of voting rights
---------------------------------------------------------------- ------------------
Other (please
specify):
--------------------------------------------------------- ----- ------------------
3. Full name of person(s) Novo A/S
subject to the
notification obligation:
(iii)
----------------------------------------------------------- -----------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- -----------------------
5. Date of the transaction 29 July 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- -----------------------
6. Date on which issuer 29 July 2016
notified:
----------------------------------------------------------- -----------------------
7. Threshold(s) that is/are Above 3%
crossed or
reached: (vi, vii)
----------------------------------------------------------- -----------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- -----------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- --------------- -------------- ---------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- -------------- -------------- ------------ ------------ -----------
Ordinary
Shares
(0.1p)
GB00B06GSH43 0 0 221,203,271 221,203,271 8.62%
--------------- --------------- -------------- -------------- ------------ ------------ -----------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------- ------------------------------ ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- ---------------- ------------------------------ -----------------------
Nominal Delta
--------------- ------------- ------------- ---------------- ------------------------------ ------------ ---------
Total (A+B+C)
------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- ---------------------------------------------------------------------
221,203,271 8.62%
------------------------------------------------- ---------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------------------------
Proxy Voting:
---------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- ------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- ------------------
13. Additional information:
------------------------------------------------------------- ------------------
14. Contact name: Heather Ludvigsen
------------------------------------------------------------- ------------------
15. Contact telephone number: +45 3527 6576
------------------------------------------------------------- ------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGUWCRUPQUMC
(END) Dow Jones Newswires
August 04, 2016 03:45 ET (07:45 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024